Cargando…

Functional recombinant human anti-HAV antibody expressed in milk of transgenic mice

Hepatitis A virus (HAV) is a wide spread pathogenic agent and is the common cause of acute Hepatitis A worldwide. Passive immunization of HAV plays an extremely important role in post-exposure prophylaxis with clinical applications often requiring large amounts of antibody. As an alternative to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ran, Rao, Man, Li, Chuan, Cao, Jingyuan, Meng, Qinglin, Zheng, Min, Wang, Meili, Dai, Yunping, Liang, Mifang, Li, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2009
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089081/ https://www.ncbi.nlm.nih.gov/pubmed/19130282 http://dx.doi.org/10.1007/s11248-008-9241-0

Ejemplares similares

A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice
por: Kui, Xiang, et al.
Publicado: (2017)

Characterization of Bioactive Recombinant Human Lysozyme Expressed in Milk of Cloned Transgenic Cattle
por: Yang, Bin, et al.
Publicado: (2011)

Purification and characterization of recombinant human bile salt-stimulated lipase expressed in milk of transgenic cloned cows
por: Wang, Yuhang, et al.
Publicado: (2017)

Transgenic milk as a method for the production of recombinant antibodies
por: Pollock, Daniel P, et al.
Publicado: (1999)

Sporadic Hepatitis A Virus PCR False-Positive Results Observed during Reflex Testing of Serum Samples Previously Tested for Anti-HAV Antibodies and Caused by Contamination with HAV RNA Present in the Reagents of the Commercial Anti-HAV Immunoassay
por: Lunar, Maja M., et al.
Publicado: (2023)

Natural Products and Their Potential Anti-HAV Activity
por: Jama-Kmiecik, Agnieszka, et al.
Publicado: (2021)

Bovine FcRn-Mediated Human Immunoglobulin G Transfer across the Milk-Blood Barrier in Transgenic Mice
por: Cui, Dan, et al.
Publicado: (2014)

Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
por: Kankam, Martin, et al.
Publicado: (2020)

HAV Immunity in Iranian Medical Students
por: Hosseini Shokouh, Seyyed Javad, et al.
Publicado: (2015)

No IL-18BP? Avoid HAV
por: Diamond, Michael S.
Publicado: (2019)

HAV Infection Associated with Hemophagocytic Syndrome
por: Aamri, H., et al.
Publicado: (2023)

Nachrichten des Deutschen Hausärzteverbands (HÄV)
Publicado: (2023)

Prevalence of HAV and HEV in the patients presenting with acute viral hepatitis
por: Rao, Pooja, et al.
Publicado: (2012)

A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
por: Zhang, Ran, et al.
Publicado: (2018)

EXPRESSION OF RECOMBINANT PROTEINS IN THE MILK OF TRANSGENIC ANIMALS
por: Meade, H.M., et al.
Publicado: (1999)

Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation
por: Flefel, Eman M., et al.
Publicado: (2017)

Production of Transgenic-Cloned Pigs Expressing Large Quantities of Recombinant Human Lysozyme in Milk
por: Lu, Dan, et al.
Publicado: (2015)

Recombinant Human Factor IX Produced from Transgenic Porcine Milk
por: Lee, Meng-Hwan, et al.
Publicado: (2014)

Production of recombinant human proinsulin in the milk of transgenic mice
por: Qian, Xi, et al.
Publicado: (2014)

Hepatitis A virus (HAV) packaging size limit
por: Konduru, Krishnamurthy, et al.
Publicado: (2009)

921. Acute HAV Infection in an Inpatient Psychiatry Unit
por: Weston, Gregory, et al.
Publicado: (2021)

In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant
por: Zhu, Julie, et al.
Publicado: (2019)

Comprehensive Assessment of Milk Composition in Transgenic Cloned Cattle
por: Zhang, Ran, et al.
Publicado: (2012)

Very low prevalence of anti-HAV in Japan: high potential for future outbreak
por: Yamamoto, Chikako, et al.
Publicado: (2019)

Over-Expression of Human Lipoprotein Lipase in Mouse Mammary Glands Leads to Reduction of Milk Triglyceride and Delayed Growth of Suckling Pups
por: Wang, Yuanyuan, et al.
Publicado: (2011)

The Medicinal Chemistry of Antihepatitis Agents I: Anti-HAV, Anti-HDV, and Anti-HEV Agents
por: Gupta, Satya P.
Publicado: (2018)

Large-scale production of recombinant human lactoferrin from high-expression, marker-free transgenic cloned cows
por: Wang, Ming, et al.
Publicado: (2017)

Sensory perception testing by monofilaments in the digits of controls and workers with HAVS
por: Poole, C. J. M., et al.
Publicado: (2020)

The HAV pattern in pediatric patients with atrioventricular node reentrant tachycardia
por: Moltedo, Jose M., et al.
Publicado: (2020)

Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1)
por: dos Santos, Gabriel Menezes Costa, et al.
Publicado: (2021)

Production of Recombinant Proteins in the Milk of Transgenic Animals: Current State and Prospects
por: Shepelev, M. V., et al.
Publicado: (2018)

Tremor and hand-arm vibration syndrome (HAVS) in road maintenance workers
por: Bast-Pettersen, Rita, et al.
Publicado: (2016)

HAV‐induced acalculous cholecystitis: A case report and literature review
por: Salajegheh, Faranak, et al.
Publicado: (2023)

A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations
por: Konduru, Krishnamurthy, et al.
Publicado: (2008)

Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows
por: Parc, Annabelle Le, et al.
Publicado: (2017)

P564: HOMOHARRINGTONINE AND CYTARABINE COMBINED WITH VENETOCLAX (HAV) FOR ADULT PATIENTS WITH DE NOVO AML
por: Luo, Xiao-Hua, et al.
Publicado: (2023)

HAV in fresh vegetables: a hidden health risk in district Mardan, Pakistan
por: Khan, Waleed, et al.
Publicado: (2014)

The Human Acellular Vessel (HAV) as a vascular conduit for infrainguinal arterial bypass
por: Farazdaghi, Armin, et al.
Publicado: (2023)

Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea
por: Lee, Sang Ho, et al.
Publicado: (2010)

Association of ZC3HAV1 single nucleotide polymorphisms with the susceptibility of Vogt-Koyanagi-Harada Disease
por: Wu, Qiuying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ah779ava777d9qugd311nshrf